2013-03-06 14:36:07 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: Jardine Cycle & Carriage Limited is an above average quality company with a neutral outlook. Jardine Cycle & Carriage Limited has strong business growth and is run by efficient management. The trend in Jardine Cycle & Carriage Limited fair value exchange rate against its closest rated-competitor, City Developments Limited, has been appreciating over the past 2 weeks. When compared to its closest competitor, Jardine Cycle & Carriage Limited shows less undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics

at:
www.sadifanalytics.com/stockmarks/company-92-C07

Report Summary for: City Developments Limited is an average quality company with a positive outlook. City Developments Limited has medium business growth and is run by efficient management. The trend in City Developments Limited fair value exchange rate against its closest rated-competitor, GuocoLeisure Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, City Developments Limited shows greater undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-92-C09

Report Summary for: CEI Contract Manufacturing Limited is an above average quality company with a neutral outlook. CEI Contract Manufacturing Limited has medium business growth and is run by passable management. The trend in CEI Contract Manufacturing Limited fair value exchange rate against its closest rated-competitor, CPH Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, CEI Contract Manufacturing Limited shows less undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-92-C11

Report Summary for: Golden Agri-Resources Ltd is an above average quality company with a neutral outlook. Golden Agri-Resources Ltd has strong business growth and is run by passable management. The trend in Golden Agri-Resources Ltd fair value exchange rate against its closest rated-competitor, Olam International Ltd, has been appreciating over the past 2 weeks. When compared to its closest competitor, Golden Agri-Resources Ltd shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-92-E5H

Report Summary for: Hong Leong Asia Ltd. is an above average quality company with a neutral outlook. Hong Leong Asia Ltd. has medium business growth and is run by passable management. The trend in Hong Leong Asia Ltd. fair value exchange rate against its closest rated-competitor, Fraser and Neave Limited, has been depreciating over the past 2 weeks. When compared to its closest competitor, Hong Leong Asia Ltd. shows greater overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-92-H22

Report Summary for: STAR Pharmaceutical Limited is a low quality company with a neutral outlook. STAR Pharmaceutical Limited has weak business growth and is run by mediocre management. The trend in STAR Pharmaceutical Limited fair value exchange rate against its closest rated-competitor, Tianjin Zhong Xin Pharmaceutical Group, has been depreciating over the past 2 weeks. When compared to its closest competitor, STAR Pharmaceutical Limited shows greater overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-92-X64


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.